Our lifestyle is becoming more and more individual, agile and independent. This also influences the way we view and use medication. Self-administration is trending wherever possible, giving patients maximum autonomy and flexibility. While self-administration of insulin is already state-of-the-art in diabetes care, it is also advancing in some areas of oncology or hormone therapy.
Along with the globally increasing number of diabetes patients, the market for insulin is growing continuously—and with it the demand for pens and other injection aids. The growing demand for pens and auto-injectors calls for flexible assembly machines that allow for a fast time-to-market of a large number of different products.




















